In addition, PTEN deletion in tumor melanoma cells inhibited T-cell mediated anticancer responses, in line with the notion that PTEN expression in melanoma tumors correlates with higher immune surveillance responses [215]. The gene discussed is PTEN; the disease is neoplasm.